Evidence map›Paper›PMID 31322994›Full record

ArticleJournal of global oncology2019

Implementation of and Early Outcomes From Anal Cancer Screening at a Community-Engaged Health Care Facility Providing Care to Nigerian Men Who Have Sex With Men.

Rebecca G Nowak, Nicaise Ndembi, Wuese Dauda, Paul Jibrin, Søren M Bentzen, Chinedu H Nnaji, Oluwole Olaomi, Teresa M Darragh, Jonathan Madukwe, Trevor A Crowell and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Rebecca G NowakUniversity of Maryland School of Medicine, Baltimore, MD.
Nicaise NdembiInstitute of Human Virology Nigeria, Abuja, Nigeria.
Wuese DaudaInstitute of Human Virology Nigeria, Abuja, Nigeria.
Paul JibrinNational Hospital, Abuja, Nigeria.
Søren M BentzenUniversity of Maryland School of Medicine, Baltimore, MD.
Chinedu H NnajiInstitute of Human Virology Nigeria, Abuja, Nigeria.
Oluwole OlaomiNational Hospital, Abuja, Nigeria.
Teresa M DarraghUniversity of California, San Francisco, CA.
Jonathan MadukweNational Hospital, Abuja, Nigeria.
Trevor A CrowellWalter Reed Army Institute of Research, Silver Spring, MD.
Stefan D BaralJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
William A BlattnerUniversity of Maryland School of Medicine, Baltimore, MD.
Manhattan E CharuratUniversity of Maryland School of Medicine, Baltimore, MD.
Joel M PalefskyUniversity of California, San Francisco, CA.
Kevin J CullenUniversity of Maryland School of Medicine, Baltimore, MD.
TRUST/RV368 Study Group
University of Maryland, Baltimore · USInstitute of Human Virology · NGNational Hospital Abuja · NGUniversity of California, San Francisco · USJohns Hopkins University · USWalter Reed Army Institute of Research · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Vu H. Duong · 2008 to 2026
$51.0M
Validation of Stigma Metrics for Marginalized Men R01MH110358 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2017 to 2021
$3.6M
Building TRUSTR01AI120913 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CHARURAT, MANHATTAN E · 2015 to 2019
$3.3M
TRUSTR01MH099001 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CHARURAT, MANHATTAN E · 2012 to 2014
$2.9M
Epidemiology Research Training for Public Health Impact in Nigeria (Epi-Nigeria)D43TW010051 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI ABIMIKU, ALASH'LE G., CHARURAT, MANHATTAN E · 2016 to 2020
$1.5M
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirusK07CA225403 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI NOWAK, REBECCA G. · 2018 to 2022
$677k
FIC NIH HHS D43 TW010051NCI NIH HHS K07 CA225403NCI NIH HHS P30 CA134274NIAID NIH HHS R01 AI120913NIMH NIH HHS R01 MH099001NIMH NIH HHS R01 MH110358PEPFAR
6 · The paper itself

Abstract

purposeAnal cancer risk is substantially higher among HIV-infected men who have sex with men (MSM) as compared with other reproductive-age adults, but screening is rare across sub-Saharan Africa. We report the use of high-resolution anoscopy (HRA) as a first-line screening tool and the resulting early outcomes among MSM in Abuja, Nigeria.

methodsFrom August 2016 to August 2017, 424 MSM enrolled in an anal cancer screening substudy of TRUST/RV368, a combined HIV prevention and treatment cohort. HRA-directed biopsies were diagnosed by histology, and ablative treatment was offered for high-grade squamous intraepithelial lesions (HSIL). HRA proficiency was assessed by evaluating the detection of squamous intraepithelial lesions (SIL) over time and the proportion biopsied. Prevalence estimates of low-grade squamous intraepithelial lesions and HSIL with 95% CIs were calculated. Multinomial logistic regression was used to identify those at the highest risk of SIL.

resultsMedian age was 25 years (interquartile range [IQR], 22-29), median time since sexual debut was 8 years (IQR, 4-12), and 59% (95% CI, 54.2% to 63.6%) were HIV infected. Rate of detection of any SIL stabilized after 200 screenings, and less than 20% had two or more biopsies. Preliminary prevalence estimates of low-grade squamous intraepithelial lesions and HSIL were 50.0% (95% CI, 44.7% to 55.3%) and 6.3% (95% CI, 4.0% to 9.3%). HIV infection, at least 8 years since anal coital debut, concurrency, and external warts were independently statistically associated with SIL.

conclusionProficiency with HRA increased with experience over time. However, HSIL detection rates were low, potentially affected by obstructed views from internal warts and low biopsy rates, highlighting the need for ongoing evaluation and mentoring to validate this finding. HRA is a feasible first-line screening tool at an MSM-friendly health care facility. Years since anal coital debut and external warts could prioritize screening.

Indexed as

AdultAnus NeoplasmsEarly Detection of CancerHIV InfectionsHomosexuality, MaleHumansLogistic ModelsMaleNigeriaPatient Outcome AssessmentPrevalenceSensitivity and SpecificitySquamous Intraepithelial LesionsSurveys and QuestionnairesYoung Adult

Identifiers

PMID31322994
PMCPMC6690628
OpenAlexW2963074230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.